Related references
Note: Only part of the references are listed.A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma
Alexandrosz Czira et al.
RESPIRATORY MEDICINE (2022)
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study
Michael E. Wechsler et al.
LANCET RESPIRATORY MEDICINE (2022)
Current unmet needs and potential solutions to uncontrolled asthma
William W. Busse et al.
EUROPEAN RESPIRATORY REVIEW (2022)
Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline
Arnaud Bourdin et al.
RESPIRATORY MEDICINE (2022)
Dupilumab is effective in type 2-high asthma patients receiving high-dose inhaled corticosteroids at baseline
Arnaud Bourdin et al.
ALLERGY (2021)
Severe Asthma in a General Population Study: Prevalence and Clinical Characteristics
Lina Ronnebjerg et al.
JOURNAL OF ASTHMA AND ALLERGY (2021)
Real-World Assessment of Asthma Specialist Visits Among US Patients with Severe Asthma
Jessica F. Most et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation
Audrey Le Floc'h et al.
ALLERGY (2020)
Phenotypes and endotypes of adult asthma: Moving toward precision medicine
Ravdeep Kaur et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
A systematic review of the adverse events and economic impact associated with oral corticosteroids in asthma
Khalid Al Efraij et al.
JOURNAL OF ASTHMA (2019)
Impact of an increase in the inhaled corticosteroid dose on blood eosinophils in asthma
Marek Lommatzsch et al.
THORAX (2019)
Oral corticosteroid exposure and adverse effects in asthmatic patients
Patrick W. Sullivan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Klaus F. Rabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study
Iida Vahatalo et al.
RESPIRATORY MEDICINE (2018)
Effectiveness of inhaled corticosteroids in real life on clinical outcomes, sputum cells and systemic inflammation in asthmatics: a retrospective cohort study in a secondary care centre
Sophie F. Demarche et al.
BMJ OPEN (2017)
Targeting key proximal drivers of type 2 inflammation in disease
Namita A. Gandhi et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
Sally Wenzel et al.
LANCET (2016)
Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry
Joan Sweeney et al.
THORAX (2016)
Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis
Peter Lange et al.
LANCET RESPIRATORY MEDICINE (2016)
The prevalence of severe refractory asthma
Pieter-Paul W. Hekking et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Type 2 inflammation in asthma - present in most, absent in many
John V. Fahy
NATURE REVIEWS IMMUNOLOGY (2015)
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Kian Fan Chung et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes
Lynn E. Macdonald et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice
Andrew J. Murphy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
Ian D. Pavord et al.
LANCET (2012)
The natural history of asthma
Charles E. Reed
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Measurement properties and interpretation of three shortened versions of the asthma control questionnaire
EF Juniper et al.
RESPIRATORY MEDICINE (2005)
Can guideline-defined asthma control be achieved? The gaining optimal asthma control study
ED Bateman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Share Paper
